1-6 of 6
Douglas B. Johnson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma

Kenneth F. Grossmann, Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Michael V. Knopp, Teresa M. Petrella, Thach-Giao Truong, Nikhil I. Khushalani, Justine V. Cohen, Elizabeth I. Buchbinder, Kari Kendra, Pauline Funchain, Karl D. Lewis, Robert M. Conry, Bartosz Chmielowski, Ragini R. Kudchadkar, Douglas B. Johnson, Hongli Li, James Moon, Zeynep Eroglu, Brian Gastman, Magdalena Kovacsovics-Bankowski, Krishna S. Gunturu, Scot W. Ebbinghaus, Sama Ahsan, Nageatte Ibrahim, Elad Sharon, Larissa A. Korde, John M. Kirkwood, Antoni Ribas
Journal: Cancer Discovery
Cancer Discov (2022) 12 (3): 644–653.
https://doi.org/10.1158/2159-8290.CD-21-1141
Published: 08 March 2022
View articletitled, Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma
Open the PDF for Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma in another window
Includes: Supplementary data
Journal Articles

Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer

Arielle Elkrief, Julie T. Wu, Chinmay Jani, Kyle T. Enriquez, Michael Glover, Mansi R. Shah, Hira Ghazal Shaikh, Alicia Beeghly-Fadiel, Benjamin French, Sachin R. Jhawar, Douglas B. Johnson, Rana R. McKay, Donna R. Rivera, Daniel Y. Reuben, Surbhi Shah, Stacey L. Tinianov, Donald Cuong Vinh, Sanjay Mishra, Jeremy L. Warner
Journal: Cancer Discovery
Cancer Discov (2022) 12 (2): 303–330.
https://doi.org/10.1158/2159-8290.CD-21-1368
Published: 09 February 2022
View articletitled, Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer
Open the PDF for Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer in another window
Journal Articles

Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti–PD-1 Refractory Melanoma

Cara Haymaker, Daniel H. Johnson, Ravi Murthy, Salah-Eddine Bentebibel, Marc I. Uemura, Courtney W. Hudgens, Houssein Safa, Marihella James, Robert H.I. Andtbacka, Douglas B. Johnson, Montaser Shaheen, Michael A. Davies, Shah Rahimian, Srinivas K. Chunduru, Denái R. Milton, Michael T. Tetzlaff, Willem W. Overwijk, Patrick Hwu, Nashat Gabrail, Sudhir Agrawal, Gary Doolittle, Igor Puzanov, Joseph Markowitz, Chantale Bernatchez, Adi Diab
Journal: Cancer Discovery
Cancer Discov (2021) 11 (8): 1996–2013.
https://doi.org/10.1158/2159-8290.CD-20-1546
Published: 01 August 2021
View articletitled, Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti–PD-1 Refractory Melanoma
Open the PDF for Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti–PD-1 Refractory Melanoma in another window
Includes: Supplementary data
Journal Articles

A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor–Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention

Spencer C. Wei, Wouter C. Meijers, Margaret L. Axelrod, Nana-Ama A.S. Anang, Elles M. Screever, Elizabeth C. Wescott, Douglas B. Johnson, Elizabeth Whitley, Lorenz Lehmann, Pierre-Yves Courand, James J. Mancuso, Lauren E. Himmel, Benedicte Lebrun-Vignes, Matthew J. Wleklinski, Bjorn C. Knollmann, Jayashree Srinivasan, Yu Li, Oluwatomisin T. Atolagbe, Xiayu Rao, Yang Zhao, Jing Wang, Lauren I.R. Ehrlich, Padmanee Sharma, Joe-Elie Salem, Justin M. Balko, Javid J. Moslehi, James P. Allison
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2021) 11 (3): 614–625.
https://doi.org/10.1158/2159-8290.CD-20-0856
Published: 02 March 2021
View articletitled, A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor–Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention
Open the PDF for A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor–Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention in another window
Includes: Supplementary data
Journal Articles

Recurrent Tumor Cell–Intrinsic and –Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early Adaptation

Chunying Song, Marco Piva, Lu Sun, Aayoung Hong, Gatien Moriceau, Xiangju Kong, Hong Zhang, Shirley Lomeli, Jin Qian, Clarissa C. Yu, Robert Damoiseaux, Mark C. Kelley, Kimberley B. Dahlman, Philip O. Scumpia, Jeffrey A. Sosman, Douglas B. Johnson, Antoni Ribas, Willy Hugo, Roger S. Lo
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2017) 7 (11): 1248–1265.
https://doi.org/10.1158/2159-8290.CD-17-0401
Published: 01 November 2017
View articletitled, Recurrent Tumor Cell–Intrinsic and –Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early Adaptation
Open the PDF for Recurrent Tumor Cell–Intrinsic and –Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early Adaptation in another window
Includes: Supplementary data
Journal Articles

Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy

Hubing Shi, Willy Hugo, Xiangju Kong, Aayoung Hong, Richard C. Koya, Gatien Moriceau, Thinle Chodon, Rongqing Guo, Douglas B. Johnson, Kimberly B. Dahlman, Mark C. Kelley, Richard F. Kefford, Bartosz Chmielowski, John A. Glaspy, Jeffrey A. Sosman, Nicolas van Baren, Georgina V. Long, Antoni Ribas, Roger S. Lo
Journal: Cancer Discovery
Cancer Discov (2014) 4 (1): 80–93.
https://doi.org/10.1158/2159-8290.CD-13-0642
Published: 07 January 2014
View articletitled, Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
Open the PDF for Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy in another window
Includes: Supplementary data